this suggests two possibilities : tunicamycin specifically inhibited the synthesis of proteoglycan core protein , or more likely a proportion of the synthesized core protein precursor ( approximately 50 % ) did not become accessible for post-translational modifications , and was possibly routed for premature degradation .
C0220781
synthesis
C1700419
proteoglycan core protein